📊 Score Breakdown
Offering Ability
20
Cash Runway
95
Float Risk
25
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
43%
💰 Capital Raise
55%
• Critical: only 2.7 months cash remaining
🔄 Reverse Split
45%
• 50-day avg $1.87 approaching $1 threshold
• Only 3 months cash — financial pressure
📉 Score Deterioration
10%
• Score in HIGH risk zone (65/100)
💹 Market Data
Market Cap$54.61M
Shares Outstanding31.38M
Float20.15M
Cash$4.17M
Debt$651.75M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 2.7% shares (2025Q4 vs prior)
33 institutional holders · 12.10M shares
#1
Kanen Wealth Management LLC
4.23M shares
#2
Nantahala Capital Management, LLC
2.12M shares
#3
CastleKnight Management LP
1.29M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest1.20M
Days to Cover33.3
% of Float5.9%
FINRA data as of Apr 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2024
4
INSIDER TRANSACTION
Apr 02, 2026
4
INSIDER TRANSACTION
Apr 02, 2026
4
INSIDER TRANSACTION
Apr 02, 2026
4
INSIDER TRANSACTION
Apr 02, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for STKS
📊 STKS FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 STKS Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.